Condition
Retinal Vein Occlusion (RVO)
Total Trials
6
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 4 (1)
Trial Status
Not Yet Recruiting4
Terminated1
Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07291960Not Yet Recruiting
Retinal Clinical Assessment With AI-derived Quantitative Information
NCT07133438Phase 4RecruitingPrimary
Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
NCT07328776Not ApplicableNot Yet Recruiting
An Assistant Model for Anti-VEGF Therapy Decision
NCT07249307Not Yet Recruiting
High-throughput Large-model-based AI-assisted Diagnosis Using OCT
NCT06879301Early Phase 1Not Yet Recruiting
Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients
NCT01946399Not ApplicableTerminatedPrimary
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Showing all 6 trials